FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2169385136> ?p ?o ?g. }

• W2169385136 endingPage "6195" @default.
• W2169385136 startingPage "6186" @default.
• W2169385136 abstract "Abstract The effect of modification of amino and guanidinium groups of rabbit antibodies directed against the negatively charged p-azobenzenearsonate hapten (anti-Rp antibodies) was studied. Purified antibodies from either a single rabbit or from serum pooled from several rabbits lost at least 85 to 90% of their combining sites when 100% of their amino groups were selectively modified with maleic anhydride and 75 to 80% of their guanidinium groups were modified by subsequent treatment with glyoxal. However, they lost 50% or less of their combining sites when only the amino groups were modified. The loss of combining sites could be prevented by the presence of specific hapten (p-nitrobenzenearsonate) during the modification reactions. These results suggest that some anti-Rp antibodies have combining sites which contain guanidinium groups, while others have combining sites which contain amino groups. It was possible to separate these antibody molecules into two such populations. Maleylated anti-Rp antibody molecules were separated into two fractions with a specific solid immunoadsorbent. Approximately half of the maleylated antibodies remained in the solution because they had lost their combining sites as a result of maleylation of an amino group in the combining sites. It was possible to recover completely the antibody activity by removing most of the maleyl groups by acid hydrolysis. These antibodies did not contain glyoxal-reactive groups in their combining sites because treatment with glyoxal either before or after hydrolysis of the maleyl groups resulted in no loss of antibody combining sites. The second fraction of the maleylated antibodies, those which were adsorbed on the solid immunoadsorbent, was eluted and treated again with maleic anhydride, and their combining sites were found to be 100% effective. This showed that there were no amino groups in the combining sites of these antibodies. When these antibodies were treated subsequently with glyoxal, 75% of their combining sites were lost, showing the presence of glyoxal-reactive groups in these sites. Modification with both maleic anhydride and glyoxal of antibodies directed against a positively charged (p-azophenyltrimethylammonium) hapten and a neutral (3-azopyridine) hapten did not result in any losses of combining sites, showing that these antibodies did not contain amino- or glyoxalreactive groups in their combining sites. This investigation showed the presence and separation of at least two distinct populations of anti-Rp antibody molecules —those with combining sites containing guanidinium or other glyoxal-reactive groups and no amino groups, and those with combining sites containing amino groups and no other glyoxal-reactive groups. Amino acid analyses of the glyoxal-modified antibodies showed that arginyl residues had been irreversibly modified. No evidence was found that any other residues had been modified. However, the possibility still exists that other residues were modified, but that the modification was reversed during hydrolysis of the antibodies. Nevertheless, the immunochemical evidence is that the important group altered was a guanidinium group, since only antibodies directed against negatively charged haptens are affected while antibodies directed against neutral and positively charged haptens are not affected." @default.
• W2169385136 created "2016-06-24" @default.
• W2169385136 creator A5025253885 @default.
• W2169385136 creator A5043655838 @default.
• W2169385136 creator A5062669387 @default.
• W2169385136 date "1968-12-01" @default.
• W2169385136 modified "2023-10-18" @default.
• W2169385136 title "Evidence for Ammonium and Guanidinium Groups in the Combining Sites of Anti-p-azobenzenearsonate Antibodies— Separation of Two Different Populations of Antibody Molecules" @default.
• W2169385136 cites W1595640113 @default.
• W2169385136 cites W1680631744 @default.
• W2169385136 cites W1732164340 @default.
• W2169385136 cites W1775749144 @default.
• W2169385136 cites W1963564471 @default.
• W2169385136 cites W1967302742 @default.
• W2169385136 cites W1974347371 @default.
• W2169385136 cites W1982990931 @default.
• W2169385136 cites W1983649348 @default.
• W2169385136 cites W1998457555 @default.
• W2169385136 cites W2001364336 @default.
• W2169385136 cites W2005246072 @default.
• W2169385136 cites W2042927136 @default.
• W2169385136 cites W2047304389 @default.
• W2169385136 cites W2055128901 @default.
• W2169385136 cites W2055229308 @default.
• W2169385136 cites W2055260280 @default.
• W2169385136 cites W2088193025 @default.
• W2169385136 cites W2090437762 @default.
• W2169385136 cites W2091637599 @default.
• W2169385136 cites W2184322688 @default.
• W2169385136 cites W2328384688 @default.
• W2169385136 cites W2330604788 @default.
• W2169385136 cites W4313372951 @default.
• W2169385136 cites W4313375509 @default.
• W2169385136 cites W2071295034 @default.
• W2169385136 doi "https://doi.org/10.1016/s0021-9258(18)94477-7" @default.
• W2169385136 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/5723462" @default.
• W2169385136 hasPublicationYear "1968" @default.
• W2169385136 type Work @default.
• W2169385136 sameAs 2169385136 @default.
• W2169385136 citedByCount "35" @default.
• W2169385136 countsByYear W21693851362020 @default.
• W2169385136 crossrefType "journal-article" @default.
• W2169385136 hasAuthorship W2169385136A5025253885 @default.
• W2169385136 hasAuthorship W2169385136A5043655838 @default.
• W2169385136 hasAuthorship W2169385136A5062669387 @default.
• W2169385136 hasBestOaLocation W21693851361 @default.
• W2169385136 hasConcept C159654299 @default.
• W2169385136 hasConcept C178790620 @default.
• W2169385136 hasConcept C185592680 @default.
• W2169385136 hasConcept C203014093 @default.
• W2169385136 hasConcept C2779870022 @default.
• W2169385136 hasConcept C55493867 @default.
• W2169385136 hasConcept C86803240 @default.
• W2169385136 hasConceptScore W2169385136C159654299 @default.
• W2169385136 hasConceptScore W2169385136C178790620 @default.
• W2169385136 hasConceptScore W2169385136C185592680 @default.
• W2169385136 hasConceptScore W2169385136C203014093 @default.
• W2169385136 hasConceptScore W2169385136C2779870022 @default.
• W2169385136 hasConceptScore W2169385136C55493867 @default.
• W2169385136 hasConceptScore W2169385136C86803240 @default.
• W2169385136 hasIssue "23" @default.
• W2169385136 hasLocation W21693851361 @default.
• W2169385136 hasOpenAccess W2169385136 @default.
• W2169385136 hasPrimaryLocation W21693851361 @default.
• W2169385136 hasRelatedWork W1531601525 @default.
• W2169385136 hasRelatedWork W2319480705 @default.
• W2169385136 hasRelatedWork W2384464875 @default.
• W2169385136 hasRelatedWork W2606230654 @default.
• W2169385136 hasRelatedWork W2607424097 @default.
• W2169385136 hasRelatedWork W2748952813 @default.
• W2169385136 hasRelatedWork W2899084033 @default.
• W2169385136 hasRelatedWork W2948807893 @default.
• W2169385136 hasRelatedWork W4387497383 @default.
• W2169385136 hasRelatedWork W2778153218 @default.
• W2169385136 hasVolume "243" @default.
• W2169385136 isParatext "false" @default.
• W2169385136 isRetracted "false" @default.
• W2169385136 magId "2169385136" @default.
• W2169385136 workType "article" @default.